- Home
- GOSS vs CARE Comparison
GOSS vs CARE Comparison
Compare GOSS & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- CARE
- Stock Information
- Founded
- GOSS 2015
- CARE 1974
- Country
- GOSS United States
- CARE United States
- Employees
- GOSS N/A
- CARE N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- CARE Major Banks
- Sector
- GOSS Health Care
- CARE Finance
- Exchange
- GOSS Nasdaq
- CARE Nasdaq
- Market Cap
- GOSS 347.8M
- CARE 396.9M
- IPO Year
- GOSS 2019
- CARE N/A
- Fundamental
- Price
- GOSS $2.47
- CARE $19.46
- Analyst Decision
- GOSS Strong Buy
- CARE Buy
- Analyst Count
- GOSS 4
- CARE 2
- Target Price
- GOSS $8.50
- CARE $21.50
- AVG Volume (30 Days)
- GOSS 3.1M
- CARE 71.3K
- Earning Date
- GOSS 08-05-2025
- CARE 10-23-2025
- Dividend Yield
- GOSS N/A
- CARE N/A
- EPS Growth
- GOSS N/A
- CARE 154.06
- EPS
- GOSS N/A
- CARE 1.36
- Revenue
- GOSS $40,237,000.00
- CARE $153,120,000.00
- Revenue This Year
- GOSS N/A
- CARE $10.85
- Revenue Next Year
- GOSS $30.65
- CARE $14.12
- P/E Ratio
- GOSS N/A
- CARE $14.31
- Revenue Growth
- GOSS N/A
- CARE 21.78
- 52 Week Low
- GOSS $0.66
- CARE $13.61
- 52 Week High
- GOSS $2.65
- CARE $20.40
- Technical
- Relative Strength Index (RSI)
- GOSS 68.08
- CARE 70.53
- Support Level
- GOSS $2.38
- CARE $18.42
- Resistance Level
- GOSS $2.65
- CARE $19.80
- Average True Range (ATR)
- GOSS 0.15
- CARE 0.43
- MACD
- GOSS 0.03
- CARE 0.11
- Stochastic Oscillator
- GOSS 76.67
- CARE 84.04
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.